Table 2. Pro- and anti-coagulation factors for patients with NC-BCS, NC-PVT and healthy controls.
| Variables | NC-BCS (n = 37) | NC-PVT (n = 74) | Healthy (n = 100) |
|---|---|---|---|
| Factor II, % | 86.7± 20.2 | 82.7± 21.8 | 91.6±16.4 |
| Factor V, % | 78.7± 27.1 | 72.8± 31.3 | 103.9±8.2 |
| Factor VII, % | 70.2± 30.7 | 76.1± 26.8 | 103.5±10.3 |
| Factor VIII, % | 139 ± 65.6 | 157 ± 74.7 | 84.1 ± 8.6 |
| Factor IX, % | 75.6 ± 19.2 | 77.6 ± 26.2 | 83.9 ± 13.2 |
| Factor X, % | 78.8 ± 19.5 | 68.1 ± 21.5 | 98.2 ± 6.8 |
| Factor XI, % | 64 ± 14.9 | 67.1 ± 30 | 87.3 ± 9.6 |
| Factor XII, % | 61.3 ± 25.9 | 53 ± 23 | 84 ± 8.5 |
| PC, % | 76.1 ± 18.3 | 71.2 ± 25 | 96.6 ± 9.9 |
| PS, % | 76.9 ± 16.2 | 66.1 ± 23 | 72.3 ± 1.5 |
| AT, % | 86.9 ± 14.7 | 74.6 ± 18.5 | 97.9 ± 5.1 |
NOTE. Values are expressed as mean ± SD. Bold Italic value indicates P > 0.05 when compared with the control group.
Abbreviations: AT, antithrombin; NC-BCS, non-cirrhotic non-tumoral Budd-Chiari Syndrome; NC-PVT, non-cirrhotic non-tumoral portal vein thrombosis; PC, protein C; PS, protein S.